Title : Regulation of vasopressin receptors in deoxycorticosterone acetate-salt hypertension.

Pub. Date : 1992 Oct

PMID : 1398892






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Regulation of vasopressin receptors in deoxycorticosterone acetate-salt hypertension. Desoxycorticosterone Acetate arginine vasopressin Rattus norvegicus
2 Since arginine vasopressin may play a role in mineralocorticoid hypertension, we examined the effects of deoxycorticosterone acetate (DOCA)-salt on vasopressin V1 and V2 receptor binding and their second messengers, inositol phosphate and adenylate cyclase, respectively, in liver and kidney to determine whether altered vasopressin receptor binding is pathogenetic in mineralocorticoid hypertension. Desoxycorticosterone Acetate arginine vasopressin receptor 2 Rattus norvegicus
3 Since arginine vasopressin may play a role in mineralocorticoid hypertension, we examined the effects of deoxycorticosterone acetate (DOCA)-salt on vasopressin V1 and V2 receptor binding and their second messengers, inositol phosphate and adenylate cyclase, respectively, in liver and kidney to determine whether altered vasopressin receptor binding is pathogenetic in mineralocorticoid hypertension. Desoxycorticosterone Acetate arginine vasopressin Rattus norvegicus
4 Since arginine vasopressin may play a role in mineralocorticoid hypertension, we examined the effects of deoxycorticosterone acetate (DOCA)-salt on vasopressin V1 and V2 receptor binding and their second messengers, inositol phosphate and adenylate cyclase, respectively, in liver and kidney to determine whether altered vasopressin receptor binding is pathogenetic in mineralocorticoid hypertension. Desoxycorticosterone Acetate arginine vasopressin receptor 2 Rattus norvegicus
5 Since arginine vasopressin may play a role in mineralocorticoid hypertension, we examined the effects of deoxycorticosterone acetate (DOCA)-salt on vasopressin V1 and V2 receptor binding and their second messengers, inositol phosphate and adenylate cyclase, respectively, in liver and kidney to determine whether altered vasopressin receptor binding is pathogenetic in mineralocorticoid hypertension. Desoxycorticosterone Acetate arginine vasopressin Rattus norvegicus